AGENUS INC Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
AGENUS INC (AGEN) had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $4.60 million as of 2012-09-30, per its 10-Q filed 2012-11-07.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2012-11-07
- 2012-09-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $4.60M.
- 2012-06-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $4.60M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2012-09-30 | $4.60M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $4.60M 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |